REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Is Seven-membered Consisting Of One Nitrogen And Six Carbons > Polycyclo Ring System Having The Seven-membered Hetero Ring As One Of The Cyclos > Tricyclo Ring System Having The Seven-membered Hetero Ring A One Of The Cyclos Tricyclo Ring System Having The Seven-membered Hetero Ring A One Of The CyclosTricyclo Ring System Having The Seven-membered Hetero Ring A One Of The Cyclos patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/11/07 - 20070010508 - Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders The present invention relates to a method for the treatment, including the maintenance treatment, of affective disorders, which comprises administering, especially every 20 to 28 hours, to said subject a therapeutically effective amount, especially an amount between about 500 and about 3000 mg, of a compound of formula (1) wherein ... 12/21/06 - 20060287298 - Pharmaceutical for treatment of neurological and neuropsychiatric disorders or a pharmaceutically acceptable salt thereof. ... 11/30/06 - 20060270658 - Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep and its pharmaceutically acceptable salts, in particular an improved regiment for the administration of the carbamazepine derivative of formula (I) and the pharmaceutically acceptable salts thereof for the treatment of patients suffering from pin, in particular neuropathic paid, and the improvement of sleep; the use of oxcarbazepine for the manufacture ... 11/16/06 - 20060258640 - Use of flibanserin in the treatment of chronic pain The invention relates to a method for the treatment of chronic pain comprising the administration of a therapeutically effective amount of flibanserin ... 11/09/06 - 20060252746 - Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure ... 11/09/06 - 20060252745 - Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure ... 11/02/06 - 20060247226 - Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions wherein R1 to R4 are defined as in claim 1, the tautomers and the stereoisomers thereof, mixtures thereof, the prodrugs and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV). ... 10/19/06 - 20060235001 - Compositions for the treatment of neoplasms The invention features a method for treating a patient having a cancer or other neoplasm by administering to the patient a composition that includes a phenothiazine and another active agent, where predetermined plasma drug levels are achieved and maintained for 12 hours or more. ... 10/19/06 - 20060235000 - Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders The present invention relates to compounds and compositions useful for reducing the risk of epileptic occurrences and/or for alleviating epileptic phenomena in patients. In accordance with the invention, the compounds and compositions have at least the following two components: a) vitamin B6-based component selected from pyridoxal, pyridoxamine, pyridoxine, their pharmaceutically ... 08/31/06 - 20060194791 - Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders The present invention relates to the use of a racemate of the compound of formula (1) consisting of at least 85% S-enantiomer and not more than 15% R-enantiomer or of pharmaceutically acceptable salts of said racemate or of the S-enantiomer of formula I or of pharmaceutically acceptable salts of said ... 07/27/06 - 20060166968 - Crystalline form of oxcarbazepine Crystalline form F of oxcarbazepine. ... 07/27/06 - 20060166967 - Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain The present invention relates to the use of a mixture of the enantiomers of a compound of Formula (I) or of pharmaceutically acceptable salts of said enantiomers consisting of at least 55% of the R-enantiomer, most preferably of at least 98% of the R-enantiomer, and not more than 45 % ... 06/22/06 - 20060135509 - Method of treating neurological diseases and disorders The present invention provides methods for treating neurological diseases and disorders. Compounds that replace or enhance the function of SMN or alleviate or reduce a phenotype of cells with low SMN protein levels are provided. Screening methods and kits for identifying such compounds also are provided. ... 05/25/06 - 20060111343 - Oxcarbazepine dosage forms Dosage forms of oxcarbazepine or a pharmaceutically acceptable salt thereof and a pH modifying agent for use in oral administration are provided. ... 05/25/06 - 20060111342 - Insecticidal tricyclic derivatives It has now been found that certain tricyclic derivatives have provided unexpected insecticidal activity. These compounds are represented by formula I: wherein R1 through R8, inclusively, and X and Y are fully described. Compositions comprising an insecticidally effective amount of at least one compound of formula I, and optionally, an ... 05/18/06 - 20060106009 - Use of caboxamides for the treatment of tinnitus The present invention relates to the use of carbarnazepine derivatives in treating tinnitus. ... 05/04/06 - 20060094709 - Methods for the treatment of bipolar disorder using carbamazepine Carbamazepine, in extended release form, is useful in the treatment of patients suffering from bipolar disorder. In order to minimize the time it takes to reach efficacy, carbamazepine, in extended release form, can be administered to the patient at an initial daily dose which is then increased in daily increments ... 04/13/06 - 20060079502 - Pharmaceutical compositions Oral dosage forms comprising oxcarbazepine which when administered to a patient display no food effect. ... 04/13/06 - 20060079501 - Compositions of an anticonvulsant and mirtazapine to prevent weight gain Disclosed are pharmaceutical compositions comprising mirtazapine and an anticonvulsant drug. Also disclosed are methods of preventing weight gain associated with the administration of mirtazapine comprising identifying a patient to whom mirtazapine is to be administered and administering to said patient a pharmaceutical composition comprising mirtazapine and an anticonvulsant drug. Further ... 03/09/06 - 20060052364 - Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors A pharmaceutical composition for treatment of pain, comprises in combination oxcarbazepine or derivative thereof as defined and a COX-2 inhibitor for simultaneous, sequential or separate use. Also provided is a method of treating a patient suffering from pain, comprising administering to the patient an effective amount of oxcarbazepine or derivative ... 02/09/06 - 20060030554 - Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease or a pharmaceutically acceptable salt, amide, ester, or prodrug thereof, Methods and compositions are disclosed for treating disease states including, but not limited to cancers, autoimmune diseases, tissue damage, central nervous system disorders, neurodegenerative disorders, fibrosis, bone disorders, polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, cardiovascular conditions, and disorders in which ... 12/22/05 - 20050282797 - Process for the preparation of oxcarbazepine and related intermediates c) purifying oxcarbazepine. ... 12/15/05 - 20050277627 - Colchinol derivatives as vascular damaging agents The invention relates to colchinol derivatives of the formula 1: wherein the substituents are as defined in the description or a pharmaceutically-acceptable salt, solvate or pro-drug thereof. The invention also relates to processes for preparing compounds of formula (1), pharmaceutical compositions of compounds of formula (1) and the use of ... 11/24/05 - 20050261278 - Selective serotonin receptor inverse agonists as therapeutics for disease Disclosed herein are pharmaceutical compositions comprising an inverse serotonin receptor agonist or a serotonin receptor antagonist and an anti-psychotic agent. Disclosed herein are also methods of treating psychotic disorders using the disclosed pharmaceutical compositions. ... 09/22/05 - 20050209215 - Method for preparing 6-aminomethyl-6,11-dihydro-5h-dibenz[b,e]azepine A production method of 6-aminomethyl-6,11-dihydro-5H-dibenz[b,e]azepin characterized in that said compound is produced via N-[(6,11-dihydro-5H-dibenz[b,e]azepin-6-yl)methyl]-o-hydroxymethylbenzamide which is prepared by reducing 2-(11H-dibenz[b,e]azepin-6-ylmethyl)-1H-isoindole-1,3(2H)-dione employing a metal hydride or a metal hydride complex in a water based alcohol, and N-[(6,11-dihydro-5H-dibenz[b,e]azepin-6-yl)methyl]-o-hydroxymethylbenzamide which is useful for the aforesaid production method. ... 06/23/05 - 20050137185 - Combinations of drugs for the treatment of neoplasms The invention features a method for treating a patient having a cancer or other neoplasm by administering to the patient chlorpromazine or a chlorpromazine analog and an antiproliferative agent simultaneously or within 14 days of each other in amounts sufficient to treat the patient. ... 06/09/05 - 20050124601 - Methods for the treatment of bipolar disorder using carbamazepine Carbamazepine, in extended release form, is useful in the treatment of patients suffering from bipolar disorder. In order to minimize the time it takes to reach efficacy, carbamazepine, in extended release form, can be administered to the patient at an initial daily dose which is then increased in daily increments ... 06/02/05 - 20050119249 - Method of treating neurodegenerative diseases using d4 and 5-ht2a antagonists, inverse agonists or partial agonists The present invention relates to methods of treating neurodegenerative diseases or disorders, such as Parkinson disease and related cognitive diseases or disorders with compounds and compositions of compounds having D4 and/or 5-HT2A antagonistic, partial agonistic or inverse agonistic activity in combination with other compounds for treating said diseases. The invention ... 06/02/05 - 20050119248 - Method of treating mental disorders using d4 and 5-ht2a antagonists, inverse agonists or partial agonists The present invention relates to methods of treating of the underlying dysregulation of the emotional functionality of mental disorders (i.e. affect instability-hypersensitivity-hyperaesthesia-dissociative phenomena- . . . ) using compounds and compositions of compounds having D4 and/or 5-HT2A antagonistic, partial agonistic or inverse agonistic activity for. The invention also relates to ... ### FreshPatents.com Support |